Idea Transcript
18 OCTOBER 2017 HEMATOLOGY PROGRAM 12.00 - 13.00
LUNCH
13.00 - 13.15
OPENING REMARKS - Birol GÜvenç - Giuseppe Saglio SESSION I - HIGHLIGHTS IN HEMATOLOGY - PRESIDENTIAL SESSION
CHAIRS: Giuseppe Saglio, Şehmus Ertop, Serdar Bedii Omay
13.15 - 13.45
Considerations After 15 years of Imatinib Therapy for CML: Lessons From the German Study IV
Rudiger Hehlmann
13.45 - 14.15
Iron Overload in MDS and in Stem Cell Transplantatıon – Is it
an Issue?
Eliezer Rachmilewitz
14.15 - 14.45
Discordance Between Scientific Evidence and HematologistsPractices: Do as I say, Not as I do
Robert Gale
14.45 - 15.15
Cord Blood Transplant: Present Situation
Daniela Cilloni
COFFEE BREAK
15.15 - 15.45
SESSION II - MULTIPLE MYELOMA - PROF. EKREM MÜFTÜOĞLU SESSION
CHAIRS: Evangelos Terpos, Zahit Bolaman, Orhan Ayyıldız
15.45 - 16.15
First-Line Multiple Myeloma Therapy
Evangelos Terpos
16.15 - 17.00
Treatmens in Relapsed / Refractory Multiple Myeloma
Meral Beksaç - Amgen Satellite
17.00 - 17.30
Novel Diagnostic and Response Criteria for Myeloma - the Role of MRD
Maria Gavriatopoulou
COFFEE BREAK
17.30 - 18.00
SESSION III - ACUTE MYELOID LEUKEMIA - PROF. ATİLLA YALÇIN SESSION
CHAIRS: Charles Schiffer, Ferit Avcu, Düzgun Özatli
18.00 - 18.30
Molecular Biology of AML
Mehmet Yılmaz
18.30 - 19.00
Induction Therapy For Hıgh-Risk AML
Charles Schiffer
19.00 - 19.30
Novel Therapies in AML
Fahrad Ravandi
19 OCTOBER 2017 07.30 - 08.15
MEET THE EXPERT SESSION
Elias Jabbour - AML Guillermo Garcia Manero - MDS Haifa Kathrin Al-Ali - MPNs
SESSION IV - ACUTE LYMPHOID LEUKEMIAS
CHAIR: Dieter Hoelzer, Ali Ünal, Deniz Sargın
08.30 - 09.00
The Essential Management of Adult ALL
Dieter Hoelzer
09.00 - 09.30
Diagnostic And Prognostic Markers in ALL
Alessandro Cignetti
09.30 - 10.00
Monoclonal Antibodies in ALL
Elias Jabbour
10.00 - 10.30
Debate: Ph-Positive Acute Lymphoblastic Leukemia: Will We Still Need Chemotherapy?
Yes: Elias Jabbour
10.30 - 11.00
Debate: Ph-Positive Acute Lymphoblastic Leukemia: Will We Still Need Chemotherapy?
No: Robin Foà
COFFEE BREAK
11.00 - 11.30
SESSION V - MYELODYSPLASTIC SYNDROME
CHAIRS: Elias Jabbour, Levent Ündar, Osman İlhan
11.30 - 12.00
Molecular Pathophysiology and Classification Of MDS
Mustafa Cetiner
12.00 - 12.30
How I Treat MDS
Guillermo Garcia Manero
12.30 - 13.00
New Therapies in MDS
Elias Jabbour
LUNCH BREAK
13.00 - 14.00
SESSION VI - ANEMIAS
CHAIRS: Hanan Hamed, Sema Anak
14.00 - 14.30
Management of Sickle Cell Disease
Charles Stark
14.30 - 15.00
New Drugs for Modulation the Erythropoiesis in Hemoglobinopathies
Antonio Piga
15.00 - 15.30
Paroxysmal Nocturnal Hemoglobinuria
Hanan Hamed
SESSION VII - CHRONIC MYELOID LEUKEMIAS
CHAIRS: Naeem Chaudhri , Rıdvan Ali
15.30 - 16.00
History Of CML
Birol Güvenç - BMS Satellite
16.00 - 16.30
Management of CML in 2017
Rıdvan Ali - BMS Satellite
16:30 - 17:00
Chronic Myelogenous Leukemia Treatment Strategies
Giuseppe Saglio
17.00 - 17.30
Response Monitoring in Chronic Myeloid Leukemia in the TFR Era
Naeem Chaudhri
17:30 - 18:00
Treatment Discontinuation in Chronic Myeloid Leukemia, When and How ?
Carmen Fava
COFFEE BREAK
18.00 - 18.30
SESSION VIII - CHRONIC MYELOPROLIFERATIVE DISORDERS
CHAIRS: Tariq Mughal, Güray Saydam
18.30 - 19.00
Current Treatment of Myeloproliferative Neoplasms
Haifa Kathrin Al-Ali
19.00 - 19.30
Jak2 Inhibıtors and What Comes Next for Patients with
BCR-ABL1- Negatıive Myeloproliferative Neoplasms
Tariq Mughal
ORAL PRESENTATIONS
CHAIRS: Emin Kaya, Mahmut Töbü, Rauf Haznedar
POSTER WALK
CHAIRS: Ahmet İfran, Ahmet Öztürk, Mehmet Dağlı
19.30 - 20.30
20 OCTOBER 2017 07.30 - 08.15
MEET THE EXPERT SESSION
Rudiger Hehlmann - CML Charles Schiffer - AML Carmino de Souza - NHLs
SESSION IX - SPECIAL TOPICS FOR NHL
CHAIRS: Carmino de Souza, Burhan Ferhanoğlu
08.30 - 09.00
Primary CNS Lymphoma; Chemo or Transplant for Young Patients?
Tayfur Toptaş
09.00 - 09.30
Chemoimmunotherapy or Chemo-Free Treatment for Follicular Lymphoma
Elif Birtaş Ateşoğlu
09.30 - 10.00
PD-1 Blockers in Relapsed Hodgkin Lymphoma and Problems of Bridging to Allo - Transplant
Hüseyin Saffet Beköz
COFFEE BREAK
10.00 - 10.30
SESSION X - AGGRESSIVE AND INDOLENT NH LYMPHOMAS
CHAIRS: Khalid Halahleh, Zafer Gülbaş
10.30 - 10.55
Anaplastic Large Cell Lymphoma; Is It a Single Entity? Treatment Modalities?
Atilla Özkan
10.55 - 11.20
Transplant in NHL; When? To Whom?
Sevgi Kalayoğlu Beşışık
11.20 - 11.45
Indolent Lymphomas: Practical Clinical Approach
Berksoy Şahin
11:45 - 12:05
Reference Biologics and Biosimilar Drugs
Mehmet Ali Özcan
LUNCH BREAK
12.05 - 13.00
SESSION XI - CHRONIC LYMPHOCYTIC LEUKEMIAS
CHAIRS: Kostas Stamatopoulos , Salih Aksu
13.00 - 13.30
Chronic Lymphocytic Leukemia: Biomarkers and Prognosis
Kostas Stamatopoulos
13.30 - 14.00
Chronic Lymphocytic Leukemia Old and New Treatments
Kostas Stamatopoulos
14.00 - 14.30
Peripheral T-Cell Lymphoma
Hanan Hamed
COFFEE BREAK
14.30 - 15.00
SESSION XII - STEM CELL TRANSPLANT
CHAIRS: Carmino de Souza, Sevgi Kalayoğlu Beşışık
15.00 - 15.25
Preparation and Detection of Biotin-Labeled Red Blood CellsFor Human Infusion
Albert Donnenberg
15.25 - 15.50
Haploidentical Transplant
Zafer Gülbaş
15.50 - 16.15
Stem Cell Transplantation For Non-Hodgkin’s Lymphoma
Carmino de Souza
16.15 - 16.40
GVHD Pathophysiology and Treatment
Khalid Halahleh
16.40 - 17.05
From Allogenic Transplantation to Precision Immune Therapy: The Role of Effector Cells
Jean-Francois Rossi
ORAL PRESENTATIONS 17.05 - 18.00
CHAIRS: Gülsüm Özet, Yıldız Aydın, Pervin Topçuoğlu
17.05 - 18.00 POSTER WALK
CHAIRS: Oral Nevruz, Oktay Bilgir, Vahap Okan
21 OCTOBER 2017 08.30 - 09.15
MEET THE EXPERT SESSION
Naeem Chaudhri - CML Hanan Hamed - CLL Tariq Mughal (Next Generation Sequencing for Hematologic Malignancies)
SESSION XIII - COAGULATION AND INFECTIONS
CHAIRS: Giuseppe Saglio, Fahri Şahin
09.30 - 10.00
D-dimer in the Diagnosis of Venous Thromboembolism
Pierre Toulon
10.00 - 10.30
Updates on Treatment in Hemophilia A and B
Bülent Antmen
10.30 - 11.00
Antifungal Management in Febril Neutropenia
Ömrum Uzun
11.00
CLOSING & LUNCH